Addex Therapeutics Ltd (ADXN) Annual Balance Sheets

Annual · GAAP · USD millions
Access ADXN quarterly Balance Sheets →
A period-by-period view of the balance sheet from Addex Therapeutics Ltd to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents1.64
Cash & Short-term Investments1.00
Trade & Other Current Receivables (IFRS combined total)-
Other Current Assets0.04
Total Current Assets1.68
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent4.68
Other Current Financial Assets0.01
Trade And Other Current Receivables0.02
Current Prepayments0.02
Rightofuse Assets0.03
Noncurrent Financial Assets0.01
Noncurrent Assets4.68
Total Assets6.36
Liabilities
Accounts Payable0.00
Other Liabilities, Current1.20
Total Current Liabilities1.20
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.20
Stockholders' Equity
Other Equity4.77
Common Stockholder's Equity4.77
Total Stockholder's Equity4.77
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Addex Therapeutics Ltd balance sheet history.

About Addex Therapeutics Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-062447

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License